AhmannAJCapehornMCharpentierGDottaFHenkelELingvayIet alEfficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial
Wczeniejsze dane z fazy 2 potwierdziy te ustalenia, pokazujc, e nawet 82% uczestnikw osigno docelowy poziom HbA1c poniej 6.5%
AAV2-GAD gene therapy for advanced Parkinsons disease: a double-blind, sham-surgery controlled, randomised trial
Unveiling the roles of the glutathione redox system in vivo by analyzing genetically modified mice
When combined with physician-led nutritional frameworks and metabolic tracking, Semaglutide optimizes cellular fat metabolism
Employer coverage continues expanding, with 44% of large companies now providing GLP-1 coverage